Vitamin D Treatment to Patients Suffering From Chronic Pain and Vitamin D Hypovitaminosis
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
|Official Title:||A Randomised, Double-blind, Placebo-controlled Study to Check Whether Vitamin D Will Lead to a Decrease in Pain Intensity in Patients Suffering From Chronic Pain and Hypovitaminosis D|
- The objective of this study is to check whether vitamin D will lead to a decrease in pain intensity compare to placebo, in patients suffering from chronic pain. [ Time Frame: one year ] [ Designated as safety issue: No ]
|Study Start Date:||January 2010|
|Study Completion Date:||October 2012|
|Primary Completion Date:||October 2012 (Final data collection date for primary outcome measure)|
|Placebo Comparator: Placebo||
Active Comparator: Vitamin D
34,500 IU vitamin D per week
Drug: Vitamin D
34,5000 IU vitamin D per week
Vitamin D is a complex nutrient that functions as a hormone to benefit numerous body tissues.
Vitamin D is naturally produced by skin exposed to ultraviolet B. Despite the fact that Israel is a sunny country, a majority of all patients, and particularly those with pain, have inadequate intake of vitamin D.
Vitamin D therapy is easy for patients to self administer, well tolerated, and very economical.
In this study, we'll check whether vitamin D will lead to a decrease in pain intensity in patients suffering from chronic low back pain.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01023490
|Tel Aviv Sourasky Medical Center, Pain Medicine Unit|
|Tel Aviv, Israel|